JP2013515742A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013515742A5 JP2013515742A5 JP2012546222A JP2012546222A JP2013515742A5 JP 2013515742 A5 JP2013515742 A5 JP 2013515742A5 JP 2012546222 A JP2012546222 A JP 2012546222A JP 2012546222 A JP2012546222 A JP 2012546222A JP 2013515742 A5 JP2013515742 A5 JP 2013515742A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- terbinafine
- preparation
- short
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 12
- 238000009472 formulation Methods 0.000 claims 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 5
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 claims 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- 150000001261 hydroxy acids Chemical class 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 229960002722 terbinafine Drugs 0.000 claims 3
- 239000002888 zwitterionic surfactant Substances 0.000 claims 3
- 208000010195 Onychomycosis Diseases 0.000 claims 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 2
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 239000002562 thickening agent Substances 0.000 claims 2
- 201000005882 tinea unguium Diseases 0.000 claims 2
- 230000000699 topical effect Effects 0.000 claims 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- 229940047648 cocoamphodiacetate Drugs 0.000 claims 1
- 229940047642 disodium cocoamphodiacetate Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 150000004666 short chain fatty acids Chemical class 0.000 claims 1
- 235000021391 short chain fatty acids Nutrition 0.000 claims 1
- 229960000699 terbinafine hydrochloride Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28996209P | 2009-12-23 | 2009-12-23 | |
| US28996709P | 2009-12-23 | 2009-12-23 | |
| US61/289,967 | 2009-12-23 | ||
| US61/289,962 | 2009-12-23 | ||
| PCT/US2010/061940 WO2011079234A2 (en) | 2009-12-23 | 2010-12-22 | Highly permeating terbinafine formulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013515742A JP2013515742A (ja) | 2013-05-09 |
| JP2013515742A5 true JP2013515742A5 (enExample) | 2014-02-13 |
| JP5829217B2 JP5829217B2 (ja) | 2015-12-09 |
Family
ID=43770418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012546222A Expired - Fee Related JP5829217B2 (ja) | 2009-12-23 | 2010-12-22 | 高浸透性テルビナフィン製剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9084754B2 (enExample) |
| EP (1) | EP2544659A2 (enExample) |
| JP (1) | JP5829217B2 (enExample) |
| CN (1) | CN102770123A (enExample) |
| AU (1) | AU2010336441B2 (enExample) |
| CA (1) | CA2785643A1 (enExample) |
| WO (1) | WO2011079234A2 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2672962T3 (pl) | 2011-02-11 | 2015-08-31 | Moberg Pharma Ab | Nowa kompozycja przeciwgrzybicza |
| EP2793833B1 (en) | 2011-12-20 | 2020-06-24 | Vyome Therapeutics Limited | Topical oil composition for the treatment of fungal infections |
| EP2664327A1 (en) | 2012-05-14 | 2013-11-20 | Almirall S.A. | Topical pharmaceutical compositions comprising terbinafide and urea |
| NL2009669C2 (en) * | 2012-10-19 | 2014-04-23 | Dutch Renewable Energy B V | Enhanced nail penetrating composition. |
| CA2894696A1 (en) | 2012-12-21 | 2014-06-26 | Teikoku Pharma Usa, Inc. | Compositions and methods for transdermal delivery of hormones and other medicinal agents |
| US8697753B1 (en) | 2013-02-07 | 2014-04-15 | Polichem Sa | Method of treating onychomycosis |
| EP2952208A1 (en) * | 2014-06-04 | 2015-12-09 | Universidade de Santiago de Compostela | Hydroalcoholic system for nail treatment |
| EP3209319B1 (en) | 2014-10-21 | 2021-07-14 | Hexima Limited | A method of treatment of fungal infections |
| KR101690765B1 (ko) * | 2015-04-17 | 2016-12-28 | 동아제약 주식회사 | 항진균성 활성물질을 포함하는 경피 제제 |
| GB201511799D0 (en) * | 2015-07-06 | 2015-08-19 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
| CN108472272A (zh) * | 2015-08-17 | 2018-08-31 | 俄亥俄州国家创新基金会 | 用于ar-12的增强的透甲递送的方法和组合物 |
| US10272054B2 (en) * | 2015-10-07 | 2019-04-30 | Exodos Life Sciences Lp | Topical antifungal compositions |
| GB201605127D0 (en) * | 2016-03-25 | 2016-05-11 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
| KR20190037229A (ko) * | 2016-06-13 | 2019-04-05 | 바이옴 테라퓨틱스 리미티드 | 상승효과적 항진균 조성물 및 그의 방법 |
| WO2017216722A2 (en) * | 2016-06-13 | 2017-12-21 | Vyome Biosciences Pvt. Ltd. | Synergistic antifungal compositions and methods thereof |
| EP3581566A3 (en) | 2016-11-28 | 2020-01-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of fungal infections |
| WO2019214838A1 (en) * | 2018-05-09 | 2019-11-14 | Eviderm Institute Ab | Use of an alcohol-containing composition for improving the skin barrier function |
| EP3802502A4 (en) * | 2018-06-04 | 2022-03-30 | Zenvision Pharma LLP | ANTIFUNGAL CUTICLE OIL COMPOSITION |
| EP3603650A1 (fr) | 2018-08-01 | 2020-02-05 | Edix O Sarl | Compositions injectables et a duree d'action prolongee pour leur utilisation dans le traitement de maladies de l'ongle et/ou pour accelerer la croissance de l'ongle |
| WO2020025683A1 (fr) | 2018-08-01 | 2020-02-06 | Edix-O Sarl | Compositions injectables a duree d'action prolongee pour leur utilisation dans le traitement de maladie de l'ongle et/ou pour accelerer la croissance de l'ongle |
| US12528964B2 (en) | 2019-03-19 | 2026-01-20 | Dow Global Technologies Llc | Aqueous dispersion comprising multistage polymeric particles |
| CN113208937A (zh) * | 2020-01-21 | 2021-08-06 | 中国医学科学院北京协和医院 | 一种角质软化组合物及其制备方法和应用及治疗灰指甲的外用复方及其制备方法和应用 |
| JP7664026B2 (ja) * | 2020-08-06 | 2025-04-17 | 沢井製薬株式会社 | エフィナコナゾール含有爪外用液 |
| JP2022117408A (ja) * | 2021-01-29 | 2022-08-10 | 花王株式会社 | 外用剤組成物 |
| CN113234028B (zh) * | 2021-04-29 | 2022-08-26 | 上海大学 | 一种5-氟尿嘧啶与肌氨酸的共晶体及其制备方法与用途 |
| CN113786382B (zh) * | 2021-11-04 | 2024-05-28 | 浙江得恩德制药股份有限公司 | 一种盐酸特比萘芬凝胶及制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7713618L (sv) | 1977-12-01 | 1979-06-02 | Astra Laekemedel Ab | Lokalanestetisk blandning |
| IT1180295B (it) | 1984-10-08 | 1987-09-23 | Durst Phototechnik Srl | Ingranditore o riproduttore fotografico a colori |
| FR2673537B1 (fr) | 1991-03-08 | 1993-06-11 | Oreal | Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes. |
| AU734429B2 (en) | 1997-05-14 | 2001-06-14 | Galen (Chemicals) Limited | Topical compositions |
| DE69918087D1 (de) * | 1998-04-17 | 2004-07-22 | Bertek Pharm Inc | Topische formulierungen zur behandlung von nagel pilzerkrankungen |
| US6368618B1 (en) | 1999-07-01 | 2002-04-09 | The University Of Georgia Research Foundation, Inc. | Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs |
| DE10035991A1 (de) * | 2000-07-24 | 2002-02-14 | Polichem Sa | Nagellackzusammensetzung |
| US20040265362A1 (en) | 2001-09-04 | 2004-12-30 | Rudy Susilo | Plaster for the treatment of dysfunctions and disorders of nail growth |
| US20030091666A1 (en) * | 2001-11-14 | 2003-05-15 | Howard Murad | Methods and compositions for treating dermatological disorders with Morinda citrifolia |
| US7138394B2 (en) | 2002-09-27 | 2006-11-21 | Alpharx Inc. | Vehicle for topical delivery of anti-inflammatory compounds |
| DK2106805T3 (da) | 2003-03-21 | 2011-08-15 | Nexmed Holdings Inc | Antifungal neglelak og anvendelsesmetode |
| EP1663148A2 (en) | 2003-08-25 | 2006-06-07 | Foamix Ltd. | Penetrating pharmaceutical foam |
| US20060078580A1 (en) * | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
| US20060078599A1 (en) | 2004-10-12 | 2006-04-13 | Mathew Ebmeier | Pharmaceutical composition applicable to body tissue |
| CA2500907A1 (en) | 2005-03-15 | 2006-09-15 | Alpharx Inc. | Vehicle for topical delivery of anti-inflammatory compounds |
| EP1858556A1 (en) | 2005-03-16 | 2007-11-28 | Alpharx Inc. | Vehicle for topical delivery of anti-inflammatory compounds |
| GB0511499D0 (en) * | 2005-06-06 | 2005-07-13 | Medpharm Ltd | Topical ungual formulations |
| US20070224261A1 (en) | 2006-03-22 | 2007-09-27 | Peter Draper | Eutectic liquid drug formulation |
| JP2009540019A (ja) * | 2006-06-14 | 2009-11-19 | ドクター・レディーズ・ラボラトリーズ・リミテッド | 局所組成物 |
| WO2008121709A1 (en) * | 2007-03-30 | 2008-10-09 | Transport Pharmaceuticals, Inc. | Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug |
| JP2011529038A (ja) | 2008-07-23 | 2011-12-01 | ターゲッティド デリバリー テクノロジーズ リミテッド | 真菌感染症の処置のための局所抗真菌製剤の投与方法 |
| WO2011014850A2 (en) * | 2009-07-31 | 2011-02-03 | Nuvo Research Inc. | Topical eutectic-based formulations |
-
2010
- 2010-12-22 AU AU2010336441A patent/AU2010336441B2/en not_active Ceased
- 2010-12-22 WO PCT/US2010/061940 patent/WO2011079234A2/en not_active Ceased
- 2010-12-22 JP JP2012546222A patent/JP5829217B2/ja not_active Expired - Fee Related
- 2010-12-22 EP EP10801340A patent/EP2544659A2/en not_active Withdrawn
- 2010-12-22 CA CA2785643A patent/CA2785643A1/en not_active Abandoned
- 2010-12-22 CN CN2010800643152A patent/CN102770123A/zh active Pending
-
2012
- 2012-06-15 US US13/525,108 patent/US9084754B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016508158A5 (enExample) | ||
| JP2011140525A5 (enExample) | ||
| WO2012085523A3 (en) | Skin sanitizer compositions comprising alcohol based emulsion | |
| WO2011079234A3 (en) | Highly permeating terbinafine formulation for treating onychomycosis | |
| JP2013534248A5 (enExample) | ||
| ECSP13012668A (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
| SG10201400685SA (en) | Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia | |
| JP2011116787A5 (enExample) | ||
| WO2014067986A8 (en) | Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis | |
| CR20120605A (es) | Formulación tópica para un inhibidor de jak | |
| MX2011011614A (es) | Acidos grasos poliinsaturados para el tratamiento de trastornos relacionados a las areas de los trastornos cardiovasculares, metabolicos e inflamatorios. | |
| HK1198921A1 (en) | Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof | |
| WO2010101742A3 (en) | Ampholytic ter-polymers for use in personal care compositions | |
| PH12013500923A1 (en) | Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative | |
| BR112012019374A2 (pt) | composição farmacêutica, pellet de liberação prolongada, composição farmacêutica oral, método para tratamento de uma doença neurodegenerativa ou um dano ao sistema nervoso em um indivíduo necessitado do mesmo e método para preparação de uma formulação de liberação prolongada de um agente ativo | |
| NZ592647A (en) | Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester | |
| AU2015275248B2 (en) | Legumain activated doxorubicin derivative as well as preparation method and application thereof | |
| RU2009101326A (ru) | Препарат для наружного применения на кожу, содержащий тритерпеновую кислоту | |
| NZ596228A (en) | Compositions and methods for the treatment of inflammation | |
| EP2827868A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH FATTY ACID ESTERS | |
| JP2014218522A5 (enExample) | ||
| ME02147B (me) | Jedinjenje sa topikalnom primjenom za aktinične keratoze | |
| BR112013000613A2 (pt) | composições secas e dispositivos que contêm tais composições secas | |
| TW201129396A (en) | Topical formulation | |
| CR20140053A (es) | Formulaciones de ácido desoxicólico y sales del mismo |